Voltar à classificação

CBOE GLOBAL MARKETS INC (CBOE)

Subavaliada
Financial ServicesFinancial Data & Stock ExchangesUnited States

Fundamental

80

Preço

$278.68

Capitalização de Mercado

$27.94B

Parte 1 · Quanto vale a empresa

Visão Geral

Cboe Global Markets runs stock, options, futures and currency exchanges — marketplaces where buyers and sellers of financial instruments meet — plus a data business that sells the trading data those markets generate. It doesn't take positions on where prices go: it earns a fee each time a trade crosses its systems, whichever way the market moves. Its best-known products are options on the S&P 500 index (SPX) and the VIX volatility index, both exclusive to Cboe.

Como gera receita

Cboe earns transaction fees on the volume of contracts and shares traded across its exchanges, plus fixed fees for market data, index licensing and connectivity that clients pay whether or not they trade. Because exclusive products like SPX options and the VIX cannot be traded anywhere else, Cboe can charge more for them than for products that also trade on rival exchanges, which is why options are the largest single share of revenue. Data and access fees provide a steadier, less volume-dependent income stream.

Receita por segmento

Options50.81%

Trading in listed options, including the exclusive SPX and VIX products, Cboe's largest and most profitable business.

Data Vantage20.2%

Market data, analytics and index products sold to trading firms and other clients, largely independent of trading volume.

North American Equities13.43%

Cboe's US stock exchanges, competing directly with NYSE and Nasdaq for equity trading volume.

Europe and Asia Pacific8.66%

Equities and derivatives trading venues outside North America.

Futures4.01%

Futures on the VIX and other Cboe-listed products.

Global FX2.92%

Institutional currency trading platform, Cboe's smallest reporting segment.

Vantagem competitiva

Efeitos de rede · Estreita

Exchanges benefit from network effects: traders go where liquidity already is, which keeps volume concentrated on a handful of venues. Cboe reinforces this with products only it can list, SPX options and the VIX, which cannot trade on any competing exchange. Everywhere else — plain equities, multi-listed options, futures — it competes on price against several rivals, and margins there face real, ongoing pressure.

O que impulsiona a procura

Cíclico

Cboe's revenue tracks how much trading happens, not any underlying trend in prices, so it can actually rise when markets get volatile and investors hedge or speculate more actively. Extended calm periods with low volatility reduce trading volume and can dent revenue, especially in the more price-competitive parts of the business like equities and multi-listed options.

Principais riscos

  • Fee competition on multi-listed products — Rival exchanges keep cutting transaction fees and incentives to win order flow on products also listed elsewhere, putting ongoing pressure on Cboe's pricing outside its exclusive franchises.
  • Volatility-dependent revenue — Trading volume, and therefore revenue, can fall sharply during extended periods of low market volatility, when investors trade and hedge less.
  • Regulatory and market-structure risk — Cboe is heavily regulated by the SEC and CFTC, and changes to market-structure rules or transaction fees imposed by regulators can directly affect its economics.
  • Dependence on licensed index products — A large share of Cboe's differentiated profitability rests on its license to list options on S&P indices; a change to that licensing relationship or a new competing product could erode the advantage.

Os argumentos a favor

Buyers argue that the exclusive SPX options and VIX franchise gives Cboe pricing power no other exchange can match, that growing retail and institutional use of options provides a structural volume tailwind, and that the Data Vantage business turns that trading activity into a second, steadier revenue stream.

Os argumentos contra

Sellers worry that fee competition keeps compressing margins everywhere outside the exclusive index-options franchise, that a prolonged period of low market volatility would directly cut trading volumes and revenue, and that the business depends on a licensing relationship for the S&P indices it does not fully control.

Dados por segmento do exercício fiscal 2025Fontes: Cboe Global Markets Reports Results for Fourth Quarter 2025 and Full Year

Written by the editors, published on 18 de agosto de 2026

Direct competitors

Who this company fights with for the same customers

Compare

Generated on 18 de setembro de 2026 with claude-haiku-4-5 — shared with all users

P/E: 26.8Score: 68Market cap: $52.85B

Nasdaq runs six US options markets and three US equities markets alongside Nordic derivatives venues and a market-data business, competing with Cboe for the same order flow, listings and data subscribers.

P/E: 21.5Score: 62Market cap: $85.84B

Through the NYSE group ICE operates US equities exchanges and the NYSE American and NYSE Arca options markets, chasing the same brokers, market makers and listed issuers as Cboe.

P/E: 22.2Score: 68Market cap: $17.92B

CME's equity-index futures and options compete with Cboe's index options and VIX futures for the same hedging and volatility-trading flow from institutions.

Miami International Holdings, Inc. (MIAX)MIAX

MIAX's four US options exchanges have taken roughly a sixth of American equity-option volume, competing head-on with Cboe's options franchise on fees and liquidity incentives.

Deutsche Börse AG (Eurex)Not tracked

Its Eurex arm is Europe's dominant venue for index derivatives and, with the Xetra cash market, competes directly with Cboe Europe for European trading volumes.

Balanço & Liquidez

Receita

$5.06B

Últimos 12 meses (até 30/06/2026)

Resultado Líquido

$1.35B

Últimos 12 meses (até 30/06/2026)

Fluxo de Caixa Livre

$1.68B

Capital Próprio Total

$5.14B

Passivo Total

$4.17B

Rácio de Liquidez

1.57

Cobertura de Juros

33.06

Dívida/EBITDA

0.99

Resultados Por Ação

Receita & Resultado Líquido

Fluxo de Caixa Livre

Decomposição dos Resultados

Demonstração histórica

Margens ao longo do tempo

A dívida ao longo do tempo

Quanto pesa a dívida

Grelha do crescimento

Crescimento — Receitas

Estimativa de Valor Justo

Caso geralSubvalorizada

Valor Justo

$417.83

Preço Atual

$278.68

Margem de Segurança

+33.3%

Intervalo de Valor Justo

$271.59 - $564.07

Dispersão entre os métodos de avaliação utilizados, não um intervalo de confiança calibrado estatisticamente.

Métodos de Estimativa

Preço-alvo dos analistas:$315.64
Fluxo de caixa descontado (DCF):$785.51
Multiplicador de lucros (P/E):$230.63
Fórmula de crescimento de Graham:$537.65
Valor da capacidade de gerar lucro (EPV):$165.28
P/B justificado:$266.99
Desconto de dividendos (Gordon):$70.62
P/FFO, fundos de operações:$187.29
Lucros de meio de ciclo:$161.33
Multiplicador sobre as receitas:$126.25
Consenso dos Analistas:Manter (10B / 12H / 3S)
Última Surpresa de Resultados:+0.41%

Métricas de Avaliação

Rácio P/E

21.46

ROE

21.4%

Rácio P/B

5.11

P/FCF

15.34

Margem Bruta

54.1%

ROIC

20.3%

Radar de Rentabilidade

Criação de Valor (Vantagem Competitiva)

ROIC

20.3%

WACC

7.7%

ROIC − WACC

+12.6 pp

O ROIC supera o custo do capital — a empresa está a criar valor para os acionistas.

Critérios de Análise Fundamental

Aprovado (22)

  • EPS shows upward trend
  • EPS CAGR 14.64%
  • Price CAGR 13.79%
  • ROIC 20.3%
  • Gross Margin 54.1%
  • P/FCF 15.34
  • Debt/Equity ratio
  • Operating Margin 34.7%
  • Positive Free Cash Flow
  • CapEx intensity
  • Current Ratio
  • Interest Coverage
  • Debt/EBITDA
  • Return on Tangible Assets
  • ROE 25.8%
  • Revenue Growth 5Y 6.6%
  • Earnings Surprise avg 4.1%
  • PEG Ratio 1.05
  • Earnings Quality (OCF/NI) 1.45
  • Share Dilution -0.5%
  • Net Margin Trend 26.7% vs 19.9%
  • Piotroski F-Score 8/9

Reprovado (5)

  • P/B Ratio 5.11
  • Low reliance on intangibles
  • Price below Graham Number
  • DCF valuation (Overvalued)
  • Analyst Consensus 40% Buy

Indisponível (1)

  • Dividend Payout NaN%

Piotroski F-Score

8/9

Saúde financeira sólida

score
criteria

Qualidade dos Resultados

1.45

Alta qualidade: resultados respaldados por caixa

Diluição de Ações

-0.5%

A recomprar ações. Favorável ao acionista

Participações institucionais

Governação

Equipa Executiva

NomeCargoIdade
Mr. Craig Steven DonohueCEO, President & Director63
Ms. Jill M. Griebenow CPAExecutive VP & CFO45
Mr. Timothy LipscombExecutive VP & CTO50
Mr. John Patrick Sexton J.D.Executive VP, General Counsel & Corporate Secretary60
Mr. Christopher Andrew IsaacsonAdvisor47
Mr. Fredric J. Tomczyk A.C.A.Director69
Mr. Scott L. JohnstonExecutive VP & COO60
Mr. Allen L. Wilkinson CPASenior VP & Chief Accounting Officer37
Mr. Kenneth William Hill C.F.A.Senior VP, Treasurer and Head of Investor Relations & Business Intelligence-
Ms. Stacie FlemingSenior Vice President of Marketing & Communications-

Risco de Auditoria

6

Risco do Conselho

1

Risco de Remuneração

3

Risco dos Direitos dos Acionistas

5

Parte 2 · O preço e o momento de entrar

Esta parte não serve para saber se a empresa vale: serve para escolher quando comprá-la, depois que os fundamentos te convenceram. Dentro: análise técnica, potencial, quedas históricas, exposição gama.

Documentos

  • Relatório anual (10-K)

    Uma visão anual do negócio, dos resultados financeiros e dos riscos da empresa.

    Arquivado em 2026-02-20

    Ver documento
  • Relatório trimestral (10-Q)

    Uma atualização sobre o desempenho financeiro dos últimos três meses.

    Arquivado em 2026-07-31

    Ver documento
  • Relatório de fato relevante (8-K)

    Um aviso sobre um fato relevante, como uma mudança na liderança ou um grande anúncio.

    Arquivado em 2026-09-29

    Ver documento

via SEC EDGAR

Histórico de Resultados

via SEC EDGAR

Latest News

Recent headlines for CBOE, sourced from Markets Gazette.

  • 8/25/2026NEUTRAL
    Kalshi Looks to Regulators to Delay Competing Products From Cboe

    Kalshi, a prediction market operator, is petitioning regulators to delay the launch of competing products by Cboe Global Markets Inc. This move highlights the growing tension between new entrants in the prediction market space and established financial exchanges. The outcome of this regulatory request could impact the competitive landscape for event contracts and derivatives, potentially affecting revenue streams and market share for both Kalshi and Cboe. Investors will monitor regulatory decisions for insights into the future of this niche financial market.

  • 7/1/2026NEUTRAL
    Cboe Seeks to List Prediction Market Type Options on Earnings Metrics

    Cboe Global Markets Inc. has submitted a proposal to U.S. regulators for approval to list a new type of all-or-nothing options contract. These options would be based on specific corporate earnings metrics, allowing traders to speculate on outcomes such as SpaceX's revenue, Nvidia's data center sales, or JPMorgan Chase & Co.'s credit loss provisions. This initiative aims to expand the range of derivative products available on Cboe's platform, potentially attracting new market participants interested in event-driven trading strategies.

  • 6/23/2026NEUTRAL
    Cboe Revives Binary Options to Compete with Kalshi, Polymarket

    Cboe Global Markets has reintroduced S&P 500 binary options, a product absent for over a decade. This move positions Cboe to directly challenge prediction market platforms like Kalshi and Polymarket, which have gained significant traction with similar offerings. The reintroduction aims to capture a share of the growing market for event-driven trading and binary contracts. While the news highlights Cboe's strategic response to market trends and competitive pressures, its direct impact on Cboe's stock price remains to be seen as the success of these contracts depends on market adoption and regulatory reception.

via Markets Gazette